Aura Biosciences, Inc.
AURA
Jodie situation report
Aura Biosciences, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 4 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- AURA's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if AURA's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind AURA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
URGNUroGen Pharma Ltd.competitorMar 2, 2026 ▾
“We are aware of several pharmaceutical companies that are developing drugs in the general fields of urology and uro-oncology, such as AstraZeneca, Aura Biosciences., Bristol Myers Squibb, CG Oncology, enGene Holdings, Ferring Pharmaceuticals, Fidia Pharmaceut…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
AURA is currently a Leader in the organic co-movement group Regulated Electric Utilities. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for AURA; it is not active in the latest market snapshot.